These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1491189

  • 1. Serum tissue polypeptide antigen (TPA) modifications after fiberoptic bronchoscopy.
    Rapellino M, Pecchio F, Ruffini E, Cianci R, Pinach S.
    Int J Biol Markers; 1992; 7(4):271-2. PubMed ID: 1491189
    [No Abstract] [Full Text] [Related]

  • 2. Monitoring lung cancer with tissue polypeptide antigen: an ancillary, profitable serum test to evaluate treatment response and posttreatment disease status.
    Buccheri G, Ferrigno D.
    Lung Cancer; 1995 Oct; 13(2):155-68. PubMed ID: 8581395
    [Abstract] [Full Text] [Related]

  • 3. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma.
    Huang MS, Jong SB, Tsai MS, Lin MS, Chong IW, Lin HC, Hwang JJ.
    Respir Med; 1997 Mar; 91(3):135-42. PubMed ID: 9135852
    [Abstract] [Full Text] [Related]

  • 4. Cytokeratin tumor marker levels in bronchial washing in the diagnosis of lung cancer.
    Trevisani L, Putinati S, Sartori S, Abbasciano V, Bagni B.
    Chest; 1996 Jan; 109(1):104-8. PubMed ID: 8549168
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical value of CYFRA 21.1, carcinoembryonic antigen, neurone-specific enolase, tissue polypeptide specific antigen and tissue polypeptide antigen in the diagnosis of lung cancer.
    Bates J, Rutherford R, Divilly M, Finn J, Grimes H, O'Muircheartaigh I, Gilmartin JJ.
    Eur Respir J; 1997 Nov; 10(11):2535-8. PubMed ID: 9426091
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Flexible fiberoptic bronchoscopy in clinical practice--a review of 100 procedures.
    Jindal SK, Behera D, Dhand R, Kashyap S, Malik SK.
    Indian J Chest Dis Allied Sci; 1985 Nov; 27(3):153-8. PubMed ID: 3837765
    [No Abstract] [Full Text] [Related]

  • 12. Fiberoptic bronchoscopy in bronchogenic carcinoma.
    Simmons DH, Chopra S.
    Chest; 1976 Dec; 70(6):694-5. PubMed ID: 1001044
    [No Abstract] [Full Text] [Related]

  • 13. Flexible fiberoptic bronchoscopy.
    Kahn MA, Whitcomb ME, Snider GL.
    Am J Med; 1976 Aug; 61(2):151-5. PubMed ID: 782237
    [No Abstract] [Full Text] [Related]

  • 14. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].
    Prévost A, Passemard F, Perdu D, Vallerand H, Deschamps F, Lavaud F, Larbre H.
    Rev Mal Respir; 1994 Aug; 11(4):379-84. PubMed ID: 7973038
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CEA, TPA and CA 15.3 in tissue and serum of breast cancer patients.
    Saccani Jotti G, Grassi C, Fontanesi M, Becchi G, Gion M.
    Int J Biol Markers; 1992 Aug; 7(4):265-6. PubMed ID: 1491185
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9.
    Buccheri GF, Ferrigno D, Sartoris AM, Violante B, Vola F, Curcio A.
    Cancer; 1987 Jul 01; 60(1):42-50. PubMed ID: 3472637
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical applications of serum markers for lung cancer.
    Ferrigno D, Buccheri G.
    Respir Med; 1995 Oct 01; 89(9):587-97. PubMed ID: 7494910
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.